
Results
7
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
7 companies
GSK
Market Cap: UK£78.2b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
UK£19.58
7D
2.4%
1Y
31.8%
Hikma Pharmaceuticals
Market Cap: UK£3.1b
Develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.
HIK
UK£14.67
7D
0.3%
1Y
-30.1%
Oxford Nanopore Technologies
Market Cap: UK£1.1b
Engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA.
ONT
UK£1.18
7D
-9.7%
1Y
-0.3%
Animalcare Group
Market Cap: UK£228.9m
Develops, sells, and distributes licensed veterinary pharmaceuticals for the companion animal, production animal, and equine veterinary markets in Europe, the Asia-Pacific, and internationally.
ANCR
UK£3.32
7D
-1.0%
1Y
17.6%
Faron Pharmaceuticals Oy
Market Cap: UK£91.3m
Operates as a clinical stage drug discovery and development company.
FARN
UK£0.45
7D
0%
1Y
-79.8%
Bioventix
Market Cap: UK£86.5m
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.
BVXP
UK£16.55
7D
-2.6%
1Y
-39.8%
OptiBiotix Health
Market Cap: UK£6.4m
A life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally.
OPTI
UK£0.062
7D
-2.4%
1Y
-46.7%